hi INDiA
South Asian Views On Global News - Update 24X7

After 94.1% efficacy, Moderna to request for emergency use authorization in US, conditional approval in Europe


US-based biotechnology giant Moderna has said it will request an emergency use authorization from the US FDA and conditional approval from the European Medicines Agency after its coronavirus vaccine showed 94.1 per cent effective rate in the trials. A couple of weeks ago, Moderna said that its COVID-19 vaccine showed to be 94.5 per cent effective in preventing the deadly disease, bringing a glimmer of hope to a world ravaged by the pandemic.

gtag('set', {'user_id': 'USER_ID'}); // Set the user ID using signed-in user_id.